A total of 11 (39%), 1 (50%), and 21 (47%) patients with WR‐, SN‐, and LN‐DLBCL, respectively, showed positive BCL2 expression (p = 0.814). Here, BCL2 is linked to diffuse large B-cell lymphoma.